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ABSTRACT 
Aim: To isolate and characterise limbal mesenchymal stem cells (LMSC) from human 
corneo-scleral rings. Materials and Methods:  Cells were isolated from corneo-scleral rings 
and cultured in a mesenchymal stem cell (MSC)-selective media and examined for 
differentiation, phenotyping and characterisation. Results: LMSC were capable of tri-lineage 
differentiation, adhered to tissue culture plastic,  expressed HLA Class I and cell surface 
antigens associated with human MSC whilst having no/ low expression of HLA Class II and 
negative haematopoietic lineage markers. They were capable for CXCL12-mediated cellular 
migration. LMSC adhered, proliferated on amniotic membrane (AM), and expressed the 
common putative limbal stem cell markers. Conclusion: Limbal-derived MSC exhibited 
plasticity, could maintain limbal markers expression and demonstrated viable growth on AM. 
 
Keywords:  limbal stem cells, limbal mesenchymal stem cells, limbal stem cell deficiency, 
amniotic membrane, ABCB5 
 
 Article highlights:  
 limbal stem cells 
 limbal mesenchymal stem cells 
 limbal stem cell deficiency 
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1.0 INTRODUCTION 
The cornea is located at the anterior part of the eye and maintenance of its transparency is 
vital for clear vision.  It consists of three major layers which are derived from different germ 
layers of which the stroma and endothelium are mesenchymal in origin. Limbal stem cell 
deficiency (LSCD) occurs due to multiple pathophysiologies that adversely affect the cornea 
leading to loss of vision. A treatment  first introduced by Pellegrini et al [1] using ex vivo 
expanded limbal epithelium on fibrin sheet as a cellular therapy has shown impressive 
advances for the treatment of LSCD and other ocular surface disorders [1-5]. A successful 
outcome was considered when there was restoration of corneal epithelium and this was 
attained in approximately 75% of cases [2, 4, 6]. The success of limbal stem cell 
transplantation is however restricted to the availability of healthy limbal tissue taken from the 
contralateral eye in autologous cases or  tissues from living related donors or cadaveric eyes 
for allogeneic transplantation. Cultures with higher frequency of  limbal stem cells or 
progenitor cells in transplanted tissue constructs have higher success rates [4]. 
 
MSC also sometimes referred as mesenchymal stromal cells are non-haematopoietic stem 
cells with regenerative ability and can differentiate into cell lineages of mesenchymal origin 
i.e. adipocytes, chondrocytes and osteocytes under optimised culture conditions [7]. 
However, due to variable defining characteristics for MSC, the Mesenchymal and Tissue 
Stem Cell Committee of the International Society for Cellular Therapy (ISCT) has defined 
several minimal requirements [8]: 1) MSC must be plastic adherent, 2) they must express 
CD105, CD73 and CD90, but lack of expression of CD45, CD34, CD14, CD11b, CD79α, 
CD19 and HLA-DR surface molecules. Thirdly they should display multi-potentiality to 
differentiate into adipocytes, osteoblasts and chondroblasts. As MSC secrete many bioactive 
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molecules e.g. cytokines, trophic and growth factors, they have become of increasing interest 
to the regenerative medicine and transplantation fields [9-12].   
 
The corneal limbus has been reported to possess stromal cells which have fibroblastic 
morphology, are adherent to plastic and able to differentiate into multiple lineages, suggestive 
of an MSC population [13-15]. Human corneal mesenchymal stromal stem cells, unlike bone 
marrow-derived MSC, develop from neural crest cells [16] and are believed to support the 
growth of limbal epithelial cells [17, 18].  
 
We aim to improve the current methods of ex vivo expanded corneal epithelial transplantation 
by investigating alternative stem cells sourced from the limbal region and grown in an MSC-
selective media and hypoxic condition.  The cells were immunophenotyped, examined for 
mRNA expression of selected human MSC markers and histologically analysed for tri-
lineage differentiation.  We also grew these cells on amniotic membrane (AM) thawed from 
frozen, a biological substrate commonly used in limbal stem cell transplantation. In addition, 
we looked at chemokine receptor CXCR4 expression and further studied CXCL12-mediated 
chemotaxis in this cell population.  
 
2.0 MATERIALS AND METHODS 
This project was conducted according to the ethical principles of the Declaration of Helsinki 
for human experiments. The use of human limbal tissues and AM was approved by the Ethics 
Committee, Faculty of Medicine, Newcastle University, and the limbal tissues were obtained 
from Central Manchester and Manchester Children’s University Hospitals (NHS Trust). The 
human AM were supplied by the National Health Service (NHS) Blood and Tissue bank, 
Liverpool, United Kingdom. All experiments were performed according to the Control of 
8 
 
Substances Hazardous to Health (COSHH and BIOCOSHH) regulations. All procedures were 
in compliance with Newcastle University safety policies. Tissue culture was carried out in 
compliance with regulations for containment of Class II pathogens. 
 
2.1 Isolation, derivation and culture of LMSC 
Cells were isolated from research grade human corneo-scleral rings supplied by the 
Manchester Eye Bank, United Kingdom, as previously described [19]. Briefly, corneo-scleral 
rings were washed with Dulbecco’s Phosphate buffered saline (PBS) and dissected into 1mm2  
radial pieces. These pieces were serially trypsinised (0.05% trypsin + 0.53mM ethylene 
diaminetetraacetic EDTA) [Gibco], for 20 minutes with gentle agitation of the suspension at 
the 10 minute point of a 20 minute cycle. After 20 minutes, the trypsin was inactivated using 
media containing 10% foetal bovine serum (FBS) [Lonza]. The cell suspension was 
centrifuged at 220G for 3 minutes. The cell pellet was then re-suspended in human MSC-
growth promotion medium (MGPM; alpha-modified Eagle’s medium (α-MEM) [Lonza], 
10% (vol/vol), FBS [Lonza], 5ng/ml human recombinant fibroblast growth factor-2 (FGF2) 
[Pepro Tech, UK]. This was repeated for a total of four cycles (we refer to this as serial 
trypsinisation). Finally the limbal cell suspensions were pooled together and centrifuged to 
obtain a cell pellet in MGPM and then seeded at 1×106cells/T75cm2 flask and incubated at 
37°C, 5% CO2, 5%O2. This protocol was selective for the growth of MSC; whilst LEC 
cultures typically require an enriched media and feeder cells [20]. Non-adherent cells were 
removed the next day and media was changed every three days thereafter. The established 
cultures of LMSC at 90% confluence were passaged by enzymatic digestion using TrypLE™ 
Express [Gibco]. 
 
i. Chondrogenic differentiation of LMSC 
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LMSC were seeded into 15ml centrifuge tubes at a cell density of 500,000 cells/ tube in 
chondrogenic differentiation medium(α-MEM, 10% FBS (vol/vol), 100μM L-ascorbic acid-
2-phosphate , 10nM dexamethasone, 400μl ITS+1 (10μg/ml insulin, 5.5μg/ml transferrin, 
5ng/ml selenium, 0.5mg/ml bovine serum albumin, 4.7μg/ml linoleic acid) [Sigma] and 
10ng/ml transforming growth factor (TGF)-β3 [R&D Systems]. Cell suspensions were 
centrifuged at 220 G for three minutes to form spherical pellets and left to incubate at 37°C, 
5% CO2,5%O2 for two weeks with medium changes every three days. Histological analysis 
for chondrogenic differentiation was then performed. Cell pellets were embedded in optimal 
cutting temperature (OCT) [BD Bioscoences] and sectioned (6µm sections) using a Leica 
CM3050 cryostat. Chondrogenic sections were stained with Safranin O to determine the 
presence of sulphated glycosaminoglycan deposition. OCT was dissolved at room 
temperature by rinsing in 70% (v/v) ethanol followed by PBS washes. Slides were flooded 
with pre-filtered Safranin O (0.1% (w/ v) Safranin O dissolved in 0.1 % (v/v) acetic acid in 
deionised water) for 5 minutes and then rinsed with deionised water.  
 
 
ii. Adipogenic differentiation of LMSC 
LMSC were seeded in MGPM into a 12-well cell culture plate at a cell density of 5×104 
cells/well and cultured until confluent. MGPM was then removed and replaced with 
adipogenic differentiation medium, STEMPRO® adipogenesis differentiation kit [Gibco]. 
From this point onwards, cultures were incubated at atmospheric oxygen (22%) 5% 
CO2incubator at 37C for 30 days with medium changes every three days. For histological 
confirmation of adipogenesis, cell cultures were stained using Oil Red O. A working solution 
of stain was freshly prepared for each analysis by diluting a stock solution of Oil Red O 
(0.3% (w/v) in 99% (v/v) isopropanol) by a third in deionised water and filtering through a 
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0.45μm filter. Cell cultures were covered with 2 ml of Oil Red O working solution and left 
for 5 minutes at room temperature. The working solution was then removed and rinsed with 
tap water until clear. A counter-stain of 2ml Haematoxylin [Sigma] was then added to cover 
the monolayer for 1 minute and rinsed with tap water until clear. 
 
iii. Osteogenic differentiation of LMSC 
LMSC were seeded in MGPM in 12-well cell culture plates at a cell density of 2.5×104 
cells/well and cultured until confluent. The culture medium was replaced with osteogenic 
differentiation medium (α-MEM, 10% (vol/vol) FBS, 10nM dexamethasone,10mM β-
glycerophosphate and 100μM L-ascorbic acid-2-phosphate). All supplementary reagents were 
purchased from [Sigma Aldrich, Poole, UK]. Cultures were incubated at 37°C, 5% CO2, 
5%O2for four weeks with medium changes every three days. Osteogenic differentiation of 
LMSC cultures were confirmed by histological staining with Alizarin Red. The cells were 
incubated in Alizarin Red (4% w/v Alizarin Red in deionised water, pH 4.2-4.4 with 10% 
(v/v) ammonium hydroxide) for 2 hours at room temperature before being rinsed with PBS. 
 
Similar number of cells (but grown in MGPM only) were cultured as negative controls and 
then subjected to staining for histological analysis for lineage differentiation.  
 
2.2 Flow cytometry 
Changes in LMSC phenotype were investigated by immunophenotyping. Cells were labelled 
with antibodies specific for cell surface antigens expressed by human MSC; CD44, CD90, 
CD105, CD146, CD166, antibodies to negative lineage haematopoietic surface antigens 
CD19, CD45, and a primary control antibody (murine IgG). Cells were also labelled with 
antibodies expressing HLA Class I and Class II. All cells were from the same cell 
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preparation. All antibodies were primarily FITC-conjugated except for anti-HLA Class II. All 
antibodies were purchased from R&D Systems. Cells were detached from tissue culture 
flasks with TrypLE express and resuspended in flow cytometry buffer solution (0.1% (w/v) 
bovine serum albumin in PBS. For direct immunofluorescence, 200,000 cells in 100µl were 
added to each tube and stained with 5μl primary antibody. After incubation for one hour at 
40C, cells were washed with buffer solution and resuspended in 200μl buffer solution before 
flow cytometry analysis.  For indirect immunofluorescence, 200,000 cells were added to each 
tube and stained with 5μl primary antibodies in100µl cell suspension. After incubation for 
one hour in 40C, cells were washed. Following that, goat anti-mouse IgG FITC-conjugated 
secondary antibody [Jackson Immunology Research Laboratory, USA] was added at a 1:25 
dilution in 100µl cell suspension; this was incubated again for 30 minutes at 40C. At the end 
of incubation, cells were washed and resuspended in 200µl of flow cytometry buffer solution. 
Samples were run using FACS Canto II [BD Biosciences] and was analysed using a FACS 
Diva software [BD Biosciences]. 
 
2.3 Immunocyto/histochemistry (ICC and IHC)    
For ICC, 40,000 LMSC were seeded in an 8-chamber slide [BD Falcon] and allowed to 
proliferate until 90% confluentin 5% O2, 5% CO2 incubator at 37°C. Upon reaching 
confluence, culture medium was removed and cells washed three times with PBS. Cells were 
fixed with cold methanol [BDH Laboratory Supplies] at -20°C for 10 minutes and ICC was 
performed as described previously [21]. Antibodies used in the study included, goat anti-
mouse monoclonal antibody to ABCB5 (1:100 dilution) [Abcam], CXCR4 (1:100 dilution) 
[R&D Systems], ∆Np63 (clone 4A4 1:50 dilution)[Santa Cruz Biotech] and goat anti-rabbit 
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polyclonal antibody to ABCG2 (1:100 dilution) [Novus Biologicals]. Negative controls were 
cells incubated without primary, but with secondary antibody.  
 
For IHC, cryosections of AM were embedded in OCT and frozen for cryosectioning. 6µm 
sections were cut on a cryostat [Leica CM3050] and mounted on silane-adhesion pre-coated 
slides for optimal histology staining [CellPath]. Slides were air-dried overnight and stored at -
20C before use. Slides were washed with PBS to remove the OCT embedding media and 
then sections stained as described previously [21]. Additionally, post-staining sections were 
incubated in Sudan Black [Fisher Scientific] for 10 minutes, washed with PBS and cover 
slipped. 
 
2.4 Transwell MigrationAnalysis 
To elucidate the signalling pathway for LEC migration to the site of injury, we looked for the 
expression of CXCR4 and its response to specific chemokine CXCL12 ligand by performing 
chemotaxis assays using transwells migration analysis. Briefly, 100,000 LMSC were 
resuspended in 300µl of defined keratinocyte serum-free medium supplemented with growth 
promoting agents (DKSFM) [Gibco] and added to the upper chamber of an 8μm pore diameter 
24-well format transwell chamber. The lower chamber was filled with 200µl media without 
cells but supplemented with CXCL12  at 0ng/ml (internal control) and 300ng/ml, for 5hours 
incubation (previously pre-optimised) in 5% CO2 incubator at 37C. After 5 hours, the 
migrant cells were stained with haematoxylin and counted using a light microscope under 
20X magnification for 5 randomly selected high power fields/ well. 
 
2.5 Microscopy and Imaging 
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All images were taken using a Nikon Digital Sight–DSFi1 camera and Nikon NIS-Elements 
D software [Nikon Metrology U.K. Ltd., Derby, UK]. Images were assembled using Adobe 
Photoshop®  CS3 [Adobe Systems]. Fluorescence microscopy was undertaken using an 
Axioplan F [Zeiss].  Images were then processed using the AxioVision40 version 4.8.2.0 
software [Zeiss]. For comparison between 2 populations, images were captured under 20X 
magnification in five random fields. Cell count was performed using Image J software. 
 
2.6 Semi-quantitative Polymerase chain reaction (sq-PCR) 
RNA was extracted using RNEasy Plus Micro Kit [Qiagen, UK] as per manufacturer’s 
instructions. RNA was quantified using a Nanodrop spectrophotometer [Thermo 
Scientific].complementary DNA (cDNA) was synthesised using a cDNA Synthesis Kit 
[Bioline,UK] as per manufacturer’s instructions. sq-PCR reactions were assembled with 12.5 
µl PCR master mix [Promega, UK], 0.5µl forward primer,  0.5µl reverse primers and 2 – 
2.5µl cDNA template and DEPC-treated water to a final volume of 25µl reactions. PCR 
reactions were amplified for each gene and conditions are summarised in Supplementary 
Table T1. 
 
2.7 Growth of LMSC on AM 
i. Plating of LMSC on AM 
Research grade cryopreserved AM obtained from NHS Blood and Transplant was used as a 
substrate for growth of LMSC. The AM was stretched under tension with two 22mm x 22mm 
cover slips placed in a 6-well plate (Supplemental Figure F1). 24,000 cells/cm2 of LMSC 
from passage 4-5 were plated directly onto the membrane, initially suspended in MGPM. On 
14 
 
the next day the media was partially substituted 50:50 with DKSFM and on the third and 
subsequent days, with DKSFM only. 100μl DKSFM was supplemented daily directly onto 
the AM. Cultures were incubated in 5% CO2 20% oxygen incubator at 37C for 5 days. At 
the end of 5 days, the media was drained from the well and the AM was rinsed with PBS and 
embedded in OCT for cryostat sections. 
 
ii. Haematoxylin and eosin (H&E) staining 
 
Frozen sections (6µm) were cut onto silane-adhesion pre-coated slides [CellPath]. Slides 
were placed in 95% ethanol for 2 minutes to dissolve OCT, and then fixed with cold 
methanol for 30 minutes. Sections were then stained with haematoxylin and eosin for 
brightfield microscopy. 
 
iii. Harvesting cells for RNA extraction  
Cells grown on AM were harvested after detachment from membrane using 0.05% trypsin-
EDTA for 3 minutes, washed with 10% FBS/PBS and centrifuged to get a cell pellet 
(labelledL-AM). LMSC were detached from T75cm2 flask using TrypLE express and 
centrifuged to get a pellet and subsequently used for RNA extraction (labelled LMSC). 
Under direct microscopic examination, an area of AM devoid of any LMSC growth was 
marked and harvested as an AM only control. The epithelial cells of the membrane were 
detached using 0.05% trypsin-EDTA for 3 minutes, washed in 10% FBS/PBS and centrifuged 
to get a cell pellet. Subsequent steps for RNA extraction followed the manufacturer’s 
instructions using RNEasy Plus Micro Kit [Qiagen].  
 
2.8 Statistical analysis 
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Descriptive statistics were used to describe means, median, or mode. Quantitative data which 
were normally distributed were analysed for comparison between 2 groups using independent 
t-test. Results with P values of less than 5% (P< 0.05) were considered statistically 
significant.  
 
3.0 RESULTS 
 
LMSC possess the tri-lineage differentiation potential of MSC 
Cells derived from LMSC were assessed for tri-lineage differentiation into chondrocytes, 
adipocytes and osteoblasts (Figure 1). LMSC showed chondrogenic differentiation as 
indicated  by positive staining with  Safranin O indicative of matrix deposition (Figure 1A),  
adipogenic differentiation as indicated by the presence of lipid vesicles within the cells that 
stained red with Oil Red O (Figure 1B) and  osteogenic differentiation as indicated by 
Alizarin Red staining for matrix mineralisation (Figure 1C). Cells cultured in MGPM only 
did not demonstrate any differentiated phenotypes and no characteristic staining with Alizarin 
Red, Safranin O or Oil Red O (Supplementary Figure F2).  
 
Transcriptional analysis confirmed the tri-linage differentiation potential of LMSC with 
differentiated cells expressing chondrocyte-specific genes aggrecan and Sox9 but lacking 
expression of collagen type X (Figure 1D). Adipogenic differentiation as confirmed by 
expression of adipophilin, adipocyte binding protein-2 and sterol regulatory-element-binding 
protein-1 (Figure 1E) and osteogenic differentiation as indicated by expression of alkaline 
phosphatase andbone sialoprotein-1 (Figure 1F). 
 
LMSC fulfil the immunophenotyping criteria for human MSC 
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Flow cytometry profiles of the immunophenotype of LMSC population are presented by dark 
grey histograms overlayed onto the representative flow cytometry profiles of the unlabelled 
cell population (light grey) histograms. Analysis of cell surface antigen expression was 
carried out by calculating the percentage shift between the labelled and unlabelled LMSC 
populations. Results of immunophenotyping showing mean percentage of positively stained 
cells from 3 biological replicates are shown in Supplementary Table T2). Positive shifts were  
indicated in CD44, CD90, CD105, CD146 and CD166 expression, and cells were in the main 
negative shift for the haematopoietic cell surface antigens CD19and CD45 expression. LMSC 
also expressed HLA Class I, but negative expression of HLA Class II (Figure 2). 
 
LMSC express putative limbal stem cell markers 
Results of ICC analysis of monolayer LMSC cultures using common limbal markers revealed 
expression of ΔNp63, ABCG2 and ABCB5 (Figure 3 panel A) compared with negative 
controls (Figure 3 panel B). 
 
 LMSC express CXCR4 and migrate in response to CXCL12 
 Chemotaxis was observed by LMSC when stimulated with CXCL12. Both cell populations 
displayed migration, however more migrant cells were observed in the LMSC population on 
addition of CXCL12 (Figure 4A and 4B) and this was due to the expression of CXCR4 
receptor as demonstrated by ICC (Figure 4C). Results of the mean number of migrant cells 
were calculated and showed statistically significant difference (P<0.05) (Figure 4D).  
 
LMSC Grow on AM and express putative limbal stem cell markers 
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LMSC were adherent on AM and observed to proliferate and achieved confluence in 
DKSFM. There was a change in cellular morphology from the slender shaped, fibroblastic 
morphology of LMSC (5A –day 3) to more rounded cell bodies on Day 5 (see high 
magnification image 5A-day 5). Histological analysis of cryostat sections of LMSC on AM at 
day 5 (5B) showed the presence of cells on the AM (asterisks) compared with AM only 
(Figure 5C). 
 
mRNA expression of common limbal markers were investigated in cells grown on AM (L-
AM), LMSC alone and epithelial cells of the AM (Figure 5D). L-AM and LMSC showed 
high expression of the transcription factor p63similar to AM. Whereas weak expression of 
CK3, a corneal epithelium differentiation marker was detected in LMSC culture, expressed in 
AM, and showed low expression in L-AM. CK3 was detected in some LMSC culture, but 
absent in other biological replicates (Supplementary Figure S3). Another corneal 
differentiation marker CK12 was also not expressed (Supplementary Figure S3). However, 
LMSC expressed mRNA for ABCB5 (5D).  
 
IHC analysis of LMSC grown on AM showed expression of ABCG2 (6A) and ABCB5 (6C), 
compared to negative controls,(6B) and (6D).   p63 was also shown to be expressed by  
LMSC on AM (6E), the staining was both nuclear and cytoplasmic. Note the same section of 
LMSC on AM in (6F) showing the cell nuclei of these cells. AM only stained for p63 
expression(6G), note the difference in the pattern of staining. 
 
DISCUSSION 
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Previous studies have demonstrated the isolation of LMSC from corneal tissue, although 
protocols varied among the investigators. Polisetty et al described  harvesting  spindle-shaped 
outgrowths from primary limbal cultures after growing them on AM[22]. What where termed  
“limbal niche cells” by Tseng group, where cells isolated from corneo-scleral rings  using 
collagenase, or with dispase and grown on matrigel [15]. The Funderburgh group used 
dispase and collagenase digestion on minced pieces of stromal tissues and successfully grew 
these cells in a selective media containing 2% FBS;  incubated in humidified atmosphere, at 
5% CO2[14, 23]. These cells have all been shown to express MSC markers [14, 15, 22, 23] 
and have been described as having angiogenic potential [15].  
 
Our group used serial trypsinisation which we believe effectively cleaved the epithelial layers 
from the stroma as shown by haematoxylin and eosin staining on cross sections of limbal 
tissues taken from each cycle (unpublished data). Further use of trypsin allowed separation of 
the epithelial layer into single cells. 
 
Cells were cultured in a selective MSC media and later in differentiation media under 
hypoxic conditions, with the exception of those being analysed for adipogenic differentiation 
which requires normal oxygen levels. Hypoxia or low oxygen tension has been shown to be a 
critical regulator of stem cell biology, through the activation of hypoxia inducible factor 
pathways and the maintenance of cellular health [24]. Hypoxia or low oxygen tension is more 
physiologically relevant to maintenance of stem cell function and differentiation [25] and in 
addition has been shown to be physiologically effective for greater cell vitality, enhanced tri-
lineage differentiation and modulation of the paracrine activity of MSC[26].  
Immunophenotyping was used to demonstrate that the cells isolated in this study had the 
characteristics of human MSC; that is they expressed markers of MSC and had had low/no 
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expression for the haematopoietic commitment markers, comparable to findings of LMSC 
immunophenotyping reported in previous studies. It has been noted that there are variations 
of cell surface antigen presentation by LMSC cultured indifferent culture media or in the 
presence of additional supplements[23], e.g. CD146+ve expressing cells were present in 
cultures with serum supplement, but no expression of CD146 was detected in cells cultured in 
commercially available serum-free media [18]. A CD34+/CD105+ve LMSC population has 
also been shown to be stem-like and have tri-lineage differentiation capabilities[27]. LMSC 
showed high expression of HLA Class I, but low/no expression of Class II, similar to 
previous findings [13, 18], which deems this cell population advantageous for allogeneic 
transplantation.  
 
Chemokines are important molecules for leukocyte migration and  mediate their effect 
through G-protein coupled 7-transmembrane chemokine receptors [28] on the cell surface of 
specific and well-defined leucocyte subsets [29].  However, some chemokine receptors are 
found on non-haematopoietic cells; including neuron and microglia[30],colonic epithelial 
cells [31], endothelial cells [32] and myocardial cells [33]. In these systems, CXCR4 played 
an important role in the interaction between the target cells and chemokine signalling through 
CXCL12 mediation.  Our LMSC expressed CXCR4 and were capable of migration and this 
was mediated by the CXCR4/CXCL12 axis. CXCR4 expression by corneal cells has been 
reported previously [35]. In addition, Polisetti et al reported that vascular endothelial growth 
factor (VEGF) was present in LMSC [34].This suggests that cornea wound healing involves 
new vascular formation and cellular migration, possibly regulated by pro-inflammatory 
cytokines via the CXCR4 - CXCL12 axis, a similar “homing mechanism” observed to occur 
in bone marrow-MSC migration for bone regeneration [35] and MSC migration to sites of 
injury [36].  
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The current study showed that LMSC fulfil the criteria for MSC tri-lineage differentiation to 
osteogenic, adipogenic and chondrogenic lineages. Oil Red O staining showed lipid laden 
cells undergoing adipogenesis, while calcium deposition was indicated by Alizarin Red 
staining, similar to previous findings in LMSC [14, 22, 27] We also showed our LMSC had 
chondrogenic potential as shown by cartilage deposition indicated by Safranin O staining.  
 
Further, LMSC showed mRNA expression for genes known to be expressed by these lineage 
specific cell types. However, our LMSC derived chondrocytes lacked expression of collagen 
type X. Collagen X is normally expressed by hypertrophic chondrocytes during endochondral 
ossification[37],which is a distinctive characteristic of bone marrow-MSC where Collagen X 
appears early in the differentiation. Lack of expression of this in our differentiated cells might 
be due to lack of maturity in our cells. Tri-lineage commitment of our LMSC shows a similar 
multipotentiality possessed by human bone marrow-MSC[38]. 
 
AM has been widely used for ocular surface diseases in the UK since 1998, the outcome of 
AM transplantation have given varying results under different conditions [39]. The beneficial 
effects of AM include its anti-angiogenic, anti-inflammatory and wound healing properties, 
making it the most common biological substrate used for tissue constructs. Long term storage 
of AM in cryopreserved media  does not appear to alter the sterility, histology or biological 
properties of the membrane[40].  
 
LMSC grown on AM rapidly became a confluent cell layer and in addition, underwent 
morphological changes from a fibroblast-like morphology [15, 41] to cells with a more 
rounded cell body with bipolar protrusions. A series of morphological changes have 
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previously been observed from outgrowths of limbal epithelial cells grown on intact versus 
denuded AM by the Tseng group [42] which might be pertinent to the changes observed in 
our cultures. In their publication, they described the morphological changes of small, 
cuboidal cells (intact AM) versus large, spindle-shaped cells (denuded AM), stratification 
(intact AM) versus two-layer cells (denuded AM), etc. These changes were attributed to a 
process of cellular maturation and differentiation by limbal epithelial cells as they dissolved 
and then reassembled AM basement membrane as they grew on the AM. 
 
Here we show that LMSC share some expression of putative markers that have been widely 
used to characterise limbal stem cells at both the level of gene and protein expression. These 
markers include - transcription factor p63and drug resistance transporter ABCG2[43-45]. p63 
is responsible for limbal epithelial proliferation [43] and the isomer ΔNp63α of the 
transcription factor plays a significant role in corneal regeneration, differentiation and wound 
healing [46].  Adenosine tri-phosphate binding cassette G2 (ABCG2) is a cell surface 
transport protein, which is preferentially expressed in a variety of adult stem cells [47-50]. 
ABCG2 is also responsible for efflux of Hoechst 33342 dye, a characteristic of the limbal 
side population cell phenotype. Side population analysis has been used to isolate enriched 
stem cell populations [21, 51-55].  
 
We also studied a new marker, ABCB5 which was recently reported to be an important 
molecular limbal marker for corneal development. ABCB5 was first identified in skin 
progenitor cells[56] and malignant melanoma cells [57]. Recently, ABCB5 has been 
demonstrated to play an important role in limbal stem cell maintenance and corneal wound 
healing, thus denoting  it as an important molecular marker for limbal stem cells[58]. We 
further characterised LMSC growing on AM. mRNA analysis revealed expression ofp63 and 
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ABCB5, while protein analysis revealed these cells expressedp63, ABCG2 and ABCB5. In 
addition, the expression of all three proteins was also maintained by LMSC grown on AM. 
While expression of p63 is generally considered to be nuclear we observed that LMSC grown 
in culture and on AM exhibited both punctuate nuclear staining and cytoplasmic staining, this 
may be indicative of cellular differentiation. Galli et al[59] reported that certain genes like 
MDM2can mediate translocation of ΔNp63from the cell nucleus to the cytoplasm under 
appropriate stimuli such as cellular differentiation. 
 
CK3 distinguishes undifferentiated LMSC from epithelial cells, and is a good marker for 
corneal epithelium and also as a negative marker for limbal stem cells [60]. We found mRNA 
expression of CK3 was not consistent in all our samples which may suggests variability 
between donors. Variability in patient-derived MSC has been reported for other MSC 
populations derived from other tissues [61]. 
 
FUTURE PERSPECTIVE 
Future studies will be directed towards proliferation and maturation of LMSC on biological 
and non-biological substrates for ocular surface reconstruction. The immunomodulatory 
effects of LMSC, e.g. paracrine secretion and functions of trophic and growth factors also 
warrant further investigation. As these cells can be expanded readily in culture, stored frozen 
and brought back up in culture, they have potential to be a useful cellular tool in allogeneic 
cellular therapy for bilateral corneal conditions. 
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EXECUTIVE SUMMARY 
Isolation, identification and characterisation of LMSC 
 A simpler way of isolating human LMSC from primary corneo-scleral tissues 
 The use of serial trypsinisation method initially harvested a heterogenous population 
of cells followed by LMSC derivations under optimised culture conditions (a selective 
MSC media and hypoxic conditions).  
 Limbal-derived MSC described in this study have characterised of human MSCs, 
exhibiting tri-lineage commitment into chondrocytes, adipocytes and osteoblasts as 
determined by histological analysis, mRNA expression and immunophenotyping. 
LMSC cultures benefit from feeder-free culture conditions and shorter duration for 
cellular differentiation 
 LMSC are plastic adherent thus easier to grow without a feeder layer or use of a 
substrate, and the conditions used here offer shorter duration of cultures (5-7 days) 
compared to 10-14 days  used for outgrowth of limbal explants in enriched media [22] 
or when using cell suspensions from primary tissues [14, 27]. 
 LMSC can grow and differentiate towards cells with a more mature  corneal epithelial 
lineage on AM  
LMSC migration through the CXCR4-CXCL12 axis isa potentially important 
signalling pathway for corneal epithelial regeneration  
 LMSC express the chemokine receptor CXCR4 (gene and protein expression) 
 Cellular migration directed by CXCR4 specific ligand CXCL12 is an important 
property for a cell population to be useful in clinical transplantation for ocular surface 
regeneration.  
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CONCLUSION 
 The MSCs derived from limbal tissues satisfied minimum criteria defining them as 
human MSCs. 
 Currently there are no clinical trials using LMSC as a cellular tool for LSCD despite 
many clinical trials using MSC in other organs such as in the lungs, intestine and liver 
for many clinical conditions such as degenerative disorders, auto-immune, 
haematological and neuromuscular disorders [62] warranting further exploration of 
this cell population. 
 LMSC can grow and differentiate on intact cryopreserved AM.  
 The preliminary data presented here on LMSC cell population suggest potential for 
this cell population to be useful in furthering our understanding of LSC biology and as 
a potential tool in developing better constructs for the treatment of ocular surface 
disorders. 
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FIGURE LEGENDS 
 
Figure 1. Characterisation of limbal MSC, N=3. Histological analysis for LMSC 
differentiated cells. (A) Safranin O staining of cartilaginous deposition (orange) on a 
representative section of a pellet generated after 2 weeks culture in chondrogenic 
differentiation media, photo inset is a magnification of the same image. (B) Oil Red O 
staining of adipogenic differentiated cells showing lipid vesicles stained bright red, nuclei 
blue, after 30 days in culture, photo inset is a magnification of the same image. (C) Alizarin 
Red staining of mineral deposition in osteogenic differentiated cells after 3 weeks in culture, 
photo inset is a magnification of the same image. Analysis of mRNA expression for genes 
expressed by LMSC that had undergone tri-lineage differentiation (N=3) for (D) 
Chondrogenic: Lane 1 Aggrecan (170 bp), lane 2 Sox9 (150 bp), lane 3 no expression to 
Collagen X (730 bp) (E) Adipogenic : Lane 1 Adipocyte differentiation-related protein 
(ADRP) or Adipophilin (150 bp), lane 2 Adipocyte binding protein-2 (130 bp), lane 3 Sterol 
regulatory element-binding protein-1 (230 bp) and (F) Osteogenic: Lane 1 Alkaline 
phosphatase (187 bp), lane 2 Bone sialoprotein-1 (161 bp). GAPDH was used as a loading 
control (100 bp). Figure 1 Panels A, B and C, reproduced with kind permission of 
reproduction from eCM journal ([www.ecmjournal.org]www.ecmjournal.org)[63] 
 
Figure 2. Immunophenotyping of LMSC, N=3. Representative histograms showing cell 
populations labelled for surface antigens expressed by human MSC; CD44, CD90, CD105, 
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CD146, CD166, haematopoietic cell markers; CD19, CD45, and HLA Class I and Class II. 
Murine IgG was used as control. Antibody profiles (dark grey) were overlayed onto the 
unlabelled population (light grey).  
 
Figure 3. Immunocytochemistry of p63, ABCG2 and ABCB5 expression in LMSC cultures 
on panel A, negative control (secondary IgG) onlyon panel B[DAPI=blue, FITC-conjugated 
secondary antibody= green, Rhodamine-conjugated secondary antibody=red]. 
 
Figure 4. CXCL12-directed migration analysis of LMSC. (A) Transwell migration analysis in 
untreated cells  (0ng/ml) showing no migrant cells (B) Cells with addition of 300ng/ml 
CXCL12, incubated for 5 hours, note more migrant LMSC (arrows). (C) Immuno 
cytochemistry analysis shows expression of CXCR4 receptor in LMSC [DAPI=blue, 
CXCR4-FITC= green] (D) Mean number of migrant LMSC /high power fields in treated and 
untreated  cells (*P<0.05, Independent t-test), N=3.  
 
Figure 5. Growth of LMSC (white arrows) on AM thawed from frozen (A) from Day 1 until 
Day 5 in culture. On Day 5, there was distinct LMSC colonies growing on AM, a magnified 
image shows changes in cellular morphology (white arrows) from spindle-shaped cells to 
rounded bodies with bipolar projections. (B) Haematoxylin and eosin staining of a cross 
section of AM with areas of LMSC growth (asterisks)(C) a cross section of AM without 
LMSC for comparison, photo insets show a magnified view.[Blue –cell nuclei, scale bar: 20 
μm]. (D) mRNA expression of p63 and CK3 in LMSC growing on AM (L-AM), LMSC only, 
and AM epithelial cells only(E) mRNA expression of ABCB5 in LMSC. GAPDH was used 
as a loading control. Figure 5A reproduced with kind permission of reproduction from eCM 
journal ([www.ecmjournal.org]www.ecmjournal.org)[63] 
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Figure 6. Immunohistochemistry of AM sections with LMSC growth. (6A) LMSC expressing 
ABCG2, (6C) ABCB5 and (6E) p63 (6B) and (6D) are negative control sections stained with 
secondary IgG only (6F) the same cross section used for p63 staining with DAPI only (6G) 
and (6H) are cross sections of AM without LMSC growth; (6G) p63 staining (6H) negative 
control with secondary IgG only. [DAPI=blue, FITC-conjugated secondary antibody= green, 
Rhodamine-conjugated secondary antibody=red].  
 
(Supplementary) Figure S1. Plating of LMSC on AM thawed from frozen. The membrane 
was kept stretched and taut using two 22mm x 22mm cover slips. The cells were plated in 
media into an area confined within a plastic ring.  
 
(Supplementary) Figure S2. Undifferentiated LMSC cultures stained with (A) Oil Red O  (B) 
Safranin O and (C) Alizarin Red as negative controls  for LMSC tri-lineage commitment 
(N=3).  
 
(Supplementary) Figure S3. mRNA expression of CK3 and CK12 in LMSC, GAPDH was 
used as a loading control. [Abbreviations: LMSC – limbal MSC, LEC - Limbal epithelial cells 
(+ve control) and NTR - no template reactions (–ve control)]  
 
TABLE LEGENDS 
 
(Supplementary) Table T1. Oligonucleotides primers and amplification conditions. *Taqman 
probe [Applied Biosystems]. 
 
(Supplementary) Table T2. Results of FACS analysis for percentage of stained-positive 
LMSC immunophenotyping for three biological replicates. (* ) N=1. 
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Supplementary Table 1 
Gene Primers Sequences Product  
Length 
(bp) 
Annealing 
temperature 
(°C) 
Amplification 
Cycles 
CHONDROGENIC  
 
   
Collagen X   730 55 35 
 Forward CAA GGC ACC ATC TCC AGG AA    
 Reverse AAA GGG TAT TTG TGG CAG CAT 
ATT 
   
Aggrecan   129 55 35 
 Forward TGA GTC CTC AAG CCT CCT GT    
 Reverse TGG TCT GCA GCA GTT GAT TC    
Sox9   150 55 35 
 Forward GACTTCCGCGACGTGGAC    
 Reverse GTTGGGCGGCAGGTACTG    
OSTEOGENIC      
Bone 
sialoprotein-1 
  161 55 35 
 Forward AAA GTG AGA ACG GGG AAC CT    
 Reverse GAT GCA AAG CCA GAA TGG AT    
Alkaline 
phosphatase 
  187 55 40 
 Forward GGT GAA CCG CAA CTG GTA CT    
 Reverse CCC ACC TTG GCT GTA GTC AT    
      
ADIPOGENIC      
SREBP-1   230 55 35 
 Forward GGA GCC ATG GAT TGC ACT TTC    
 Reverse ATC TTC AAT GGA GTG GGT GCA G    
Adipocyte 
binding protein-2 
(aP2) 
  130 55 35 
 Forward ATGGGATGGAAAATCAACCA    
 Reverse GTGGAAGTGACGCCTTTCAT    
Adipophilin   200 55 35 
 Forward CGCTGTCACTGGGGCAAAAGA    
 Reverse ATCCGACTCCCCAAGACTGTGTTA    
LIMBAL STEM 
CELL MARKERS 
     
Δp63α  
 
143 55 35 
 Forward GTGATGATGGTTCACGTTGG    
 Reverse ACATGACGTCGGGTGTTTTT    
CK3   145 53 35 
 Forward GGATGTGGACAGTGCCTATATG    
 Reverse AGATAGCTCAGCGTCGTAGAG    
ABCG2  
 
143 55 35 
 Forward GCGTGCTGTGCCCACTCAAA    
 Reverse AGCATGTGCACGGTGCGTTC    
ABCB5* 
Hs 02889060_m1 
 N/A 98 55 35 
GAPDH   100 55 35 
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 Forward ATG GGG AAG GTG AAG GTC G    
 Reverse TAA AAG CAG CCC TGG TGA CC    
      
Supplementary Table T1. Oligonucleotides primers and amplification conditions. *Taqman probe 
[Applied Biosystems]. 
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Supplementary Table 2 
 
Markers Mean SE 
Unlabeled 0.5 0 
CD44 78 2.06 
CD90 70 6.54 
CD105 78 8.9 
CD166 74 10.7 
CD146 55 10.7 
CD19 7.6 2.1 
CD45 6.8 2.5 
*HLA Class I 100 0 
*HLA Class II 0.5 0 
IgG 19.4 8.5 
Supplementary Table T2. Results of FACS analysis for percentage of stained-positive LMSC 
immunophenotyping for three biological replicates. (* ) N=1. 
 
